Advanced search
Publication Cover
Journal of Microencapsulation
Micro and Nano Carriers
Volume 16, 1999 - Issue 3
Submit an article Journal homepage
5
Views
0
CrossRef citations to date
0
Altmetric
Research Article

LITERATURE ALERTS

Pages 395-407 | Published online: 29 Sep 2008

LITERATURE ALERTS

  • A glycoprotein from rat liver endoplasm ic reticulum prom otes both aggregation and fusion of liposom es at acidic pH. CORAZZI, L., MONNI, M., PLACID', M., and ROBERTI, R. J. Membr. Biol., 1998, 165 (1), 53–63.
  • A microencapsulated Lew is acid. A new type of polym er-supported Lew is acid catalyst of wide utility in organic synthesis. KOBAYASHI, S., and NAGAYAMA, S. J. Am. Chem. Soc., 1998, 120 (18), 4554.
  • A microsphere imm unoabsorption experim ent. Serum IgG test of rabbit antisera to hum an. TANG, Z., MA, Y., Li, G., JIANG, S., WANG, C., and MA, J. Guangxi Shifan Daxue Xuebao, Ziran Kexueban, 1997, 15 (2), 72–76.
  • A novel method for high-yield entrapm ent of solutes into small liposom es. ZADI, B., and GREGORIADIS, G. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 402–403. Acrylic microspheres for water-soluble drug. LEE, J. H., and CHoi, H. K. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 810–811.
  • Activity of liposom al am photericin B with prolonged circulation in blood versus those of Am Bisom e and Fungizone against intracellular Candida albicans in m urine peritoneal 111 acroph ages. VAN ETTEN, E. W. M., VAN VIANEN, W., HAK, J., and BAKKER, W. I. A. J. M. Antimicrob. Agents Chemother., 1998, 42 (9), 2437–2439.
  • Adjuvancy enhancem ent of m uram yl dipeptide by controlling its release from ov album in m icrospheres. PURI, N., and SINKO, P. J. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 216–217.
  • Administration of liposom al agents and blood clearance capacity of the mononuclear phagocyte system. VAN ETTEN, E. W., TEN KATE, M. T., SNIJDERS, S. V., and BAKKER WOUDENBERG, I. A. Antimicrob. Agents Chemother., 1998, 42 (7), 1677–1681.
  • Adsorption of chitin derivatives onto liposom es: optimization of adsorption conditions. MOBED, M., and CHANG, T. M. S. J. Mcroencapsulation, 1998, 15 (5), 595–607.
  • AFM images of cationic liposom es coin plexes with plasm id DNA. KAWAURA, C., FURUNO, T., and NAKANISHI, M. Bioimages, 1997, 5 (4), 121–125.
  • Aggregation of dim yristoylphosphatidylglycerol liposom es by hum an plasm a low density lipoprotein. LAURAEUS, S., HOLOPAINEN, J. M., TASKINEN, M. R., and KINNUNEN, P. K. Biochim. Biophys. Acta, 1998, 1373 (1), 147–162.
  • Album in improves the delivery of tetanus toxoid from PLGA microspheres. JOHANSEN, P., MERKLE, H. P., and GANDER, B. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 633–634.
  • Alveolar m acrophage cell line is not activated by exposure to polym eric microspheres. NG, K. Y., STRINGER, K. A., COHEN, Z., SERRAVO, R., TIAN, B., MEYER, J. D., FALK, R., RANDOLPH, T., MANNING, M. C., and THOMPSON, D. C. Int. J. Pharm., 1998, 170 (1), 41–49.
  • Am Bisom e (liposom at am photericin B): a corn parative review. BOSWELL, G. W., BUELL, D., and BEKERSKY, I. J. Clin. Pharmacol., 1998, 38 (7), 583–592.
  • Am phiphilic poly(Ala)-b-poly(Sar)microspheres loaded with hydrophobic drug. KIDCHOB, T., KIMURA, S., and IMANISHI, Y. J. Controlled Release, 1998, 51 (2-3), 241–248.
  • An engineering model to characterize oxygen transfer rates for liposom e encapsulated hem oglobin (LEH). CHUNG, T. W., and PENG, I. H. Artif. Cells, Blood Substitutes, Immobiliza-tion Biotechnol., 1998, 26 (4), 389–398.
  • An experim ental model of acute encephalopathy after total body irradiation in the rat: effect of liposom e-entrapped Cu/Zn superoxide dismutase. LAMPROGLOU, I., MAGDELENAT, H., BOISSERIE, G., BAILLET, F., MAYO, W., FESSI, H., PUISIEUX, F., PERDERAU, B., COLAS LINTHART, N., and DELATTRE, J. Y. Int. J. Radiat. Oncol. Biol. Phys., 1998, 42 (1), 179–184.
  • An inverted hexagonal phase of cationic liposom e-DNA corn plexes related to DNA release and delivery. KOLTOVER, I., SALDITT, T., RADLER, J. O., and SAFINYA, C. R. Science ( Washing-ton, DC), 1998, 281 (5373), 78–81.
  • Antioxidant activities of isoflavones and their biological m etabolites in a liposom al system. ARGRA, A., NAIR, M. G., and STRASBURG, G. M. Arch. Biochem. Biophys., 1998, 356 (2), 133–141.
  • Antioxidant and pro-oxidant effects of epinephrine and isopren aline on peroxidation of LDL and lipid liposom es. ONDRIAS, K., STASKO, A., GERGEL, D., HROMADOVA, M., and MISIK, V. Physiol. Res., 1998,, 47 (2), 119–124.
  • Antitum or activity of 5-0-dipalm itoylphosphatidyl 2 -C-cyano-2 -a e xy-113-D-arabinofurano-sylcytosine is enhanced by long-circulating liposomalization. ASAI, T., KUROHANE, K., SHUT°, S., AWANO, H., MATSUDA, A., TSUKADA, H., NAMBA, y., OKADA, S., and ORu, N. Biol. Pharm. Bull., 1998, 21 (7), 766–771.
  • Antitum or immunity induction by intracellular hyperthermia using m agnetite cationic liposom es. YANASE, M., SHINTKAI, M., HONDA, H., WAKABAYASHI, T., YOSHIDA, J., and KOBAYA-SHI, T. Jpn. J. Cancer Res., 1998, 89 (7), 775–782.
  • Application of m icrocapsule technology to the detergent builder. SANG, H., LING, A., and Jmo, Q. Beijing Gongye Daxue Xuebao, 1998, 24 (1), 93–96.
  • Aqueous tw O-phase affinity partitioning of biotinylated liposom es using neutral avidin as affinity ligand. EKBLAD, L., KERNBICHLER, J., and JERGIL, B. J. Chromatogr., A, 1998, 815 (2), 189–195.
  • Assessm ent of protein integrity within biodegradable m icrospheres. YANG, T., DONG, A., MEYER, J., JOHNSON, O. L., CARPENTER, J. F., and CLELAND, J. L. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 257–258.
  • Association of liposom es containing a soybean-derived steryl glucoside mixture with rat prim ary cultured hepatocyte S. SHIMIZU, K., MAITANI, Y., TAKAHASHI, N., TAKAYAMA, K., and NAGAI, T. Biol. Pharm. Bull., 1998, 21 (8), 818–822.
  • Atomic force microscopy used for the surface characterization of microcapsule imm unoi-solation devices. Xu, K., HERCULES, D. M., LACIK, I., and WANG, T. G. J. Biomed. Mater. Res., 1998, 41 (3), 461–467.
  • Beta-Glucuronidase activity following corn plex coacervation and spray drying m icroencap-sulation. BURGESS, D. J., and PONSART, S. J. Microencapsulation, 1998, 15 (5), 569–579.
  • Beverage flavor em ulsion—a form of emulsion liquid membrane microencapsulation. TAN, C. T. Dev. Food Sci., 1998, 40 (Food Flavors: Formation, Analysis, and Packaging Influences), 29–42.
  • Biochem ical and ultrastructural characterization of fluid transporting LLC-PK1 m icro-sph eres. ANDERSEN, K. J., MAUNSBACH, A. B., and CHRISTENSEN, E. I. J. Am. Soc. Nephrol., 1998, 9 (7), 1153–1168.
  • Biochemical effects of conventional liposom es in mice brain. YURASOV, Y. Y., KUCHERYANU, V. G., PODOORNI, G. N., KUDRIN, V. S., KAPLUN, A. P., ZHIGALTSEV, I. V., and SHVETS, V. I. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 394–395.
  • Biodegradable microspheres having reactive groups prepared with poly (lactic acid-co-depsipeptide). HAMADA, A., OHYA, Y., and OucHi, T. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 727–728.
  • Biodegradable poly(L, L-lactide) microspheres. Particles from earlier synthesized polym ers and by ring-opening polymerization of L, L-lactide. SuamxowsKi, S., and SOSNOVvSKI, S. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1998, 39 (2), 212–213.
  • Biodegradable, som atostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods. HERRMANN, J., and BODMEIER, R. Eur. J. Pharm. Biopharm., 1998, 45 (1), 75–82.
  • Biodegradation of poly(ethylene adipate)microcapsules in physiological media. ATKINS, T. W. Biomaterials, 1998, 19 (1-3), 61–67.
  • Biological effects and cellular uptake of c-m yc antisense oligonucleotides and their cationic liposom e com plexes. KANAMARU, T., TAKAGI, T., TAKAKURA, Y., and HASHIDA, M. J. Drug Target., 1998, 5 (4), 235–246.
  • Biologically active cam ptothecin derivatives for incorporation into liposome bilayers and lipid emulsions. LUNDBERG, B. B. Anti Cancer Drug Des., 1998, 13(5), 453–4.61.
  • Catalytic properties of galactose oxidase to liposom e-forming am phiphiles which have many pendent galactose residues. OHNO, K., and KITANO, H. Bioconjugate Chem., 1998, 9 (5), 548–554.
  • Cationic liposom es for gene therapy. MILLER, A. D. Angew. Chem., Int. Ed., 1998, 37(13/14), 1769–1785.
  • Cationic m ultilam ellar liposom e-m ediated hum an in te rfe ron-b-gene transfer into cervical cancer cell. TOMODA, K., OHISHI, N., KIKKAWA, F., MIZUTANI, S., TOMODA, Y., and YAGI, K. Anticancer Res., 1998, 18 (3A), 1367–1371.
  • Cationization of liposom al surface charge enhances adjuvant effect of liposom es for turn or vaccine. NAKANISHI, T., KUNISAWA, J., HAYASHI, A., TSUTSUMI, Y., HAYAKAWA, T., and MAYUMI, T. Yakuzaigetku, 1998, 58 (2), 59–68.
  • Characteristics of oligonucleotides entrapped into liposom al form ulations. SHop, y., SHIMADA, J., and MIZUSHIMA, Y. Proc. Int. Symp. Controlled Release Bioact. Metter., 1998, 25th, 346–347.
  • Cholesterol incorporation in liposom al membrane: change in v an't Hoff enthalpy. DE, S., BASU, R., and NANDY, P. J. Indian Chem. Soc., 1998, 75 (7), 405–406.
  • Cisplatin microspheres for breast cancer therapy. Liu, C. W., KOOMEN, J., Yu, D. F., KUANG, L. R., and YANG, D. J. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 709–710.
  • Co-encapsulation of additives improved entrapm ent and release of a som atostatin analog in PLGA microspheres. BLANCO, P. M. J., ORSOUNI, P., HEIMGARTNER, F., BESSEGHIR, K., MERKLE, H. P., and GANDER, B. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 499–500.
  • Comparison of different hydrophobic anchors conjugated to poly (ethylene glycol): effects on the ph arm acokinetics of liposom al vincristine. WEBB, M. S., SAXON, D., WONG, F. M. P., Lim, H. J., WANG, Z., BALLY, M. B., CHOI, L. S. L., C'tfLus, P. R., and MAYER, L. D. Biochim. Biophys. Acta, 1998, 1372 (2), 272–282.
  • Corn parison of polym erically stabilized PEG-grafted liposom es, and physically adsorbed carboxym ethylchitin and carboxymethyl/glycolchitin liposom es for biological appli-cations. MOBED, M., and CHANG, T. M. S. Biomaterials, 1998, 19 (13), 1167–1177.
  • Comparison of the immunological and protective responses elicited by microencapsulated formulations of the Fl antigen from Yersinia pestis. REDDIN, K. M., EASTERBROOK, T. J., ELEV, S. M., RUSSELL, p., MOBSBY, V. A., JoNEs, D. H., FARRAR, G. H., WILLIAMSON, E. D., and ROBINSON, A. Vaccine, 1998, 16 (8), 761–767.
  • Complete suspension of microcapsules in baffled and unbaffled stirred tanks. BRIrjEs, L., LEGRAND, J., and CARNELLE, G. Chem. Thg. TechnoL, 1998, 21(9), 735–744.
  • Conjugation approach of drug to biodegradable poly(DL-lactic-co-glycolic acid) for controlled release from m icrospheres. NAM, Y. S., LEE, K. H., and PARK, T. G. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1998, 39 (2), 216–217.
  • Construction of transferrin-PEG-liposom es for intracellular drug delivery in solid turn or in vivo. MARUYAMA, K., TANAHASHI, H., ISHIDA, O., and IWATSURU, M. Proc. Mt. Symp. Controlled Release Bioact. Mater., 1998, 25th, 864–865.
  • Contribution of polym ers to the design and development of m icroencapsulated systems of biom edical interest. GALLARDO, A., and ROMAN, J. S. Rev. Plast. Mod, 1998, 75 (504), 577–586.
  • Contribution of tryptophan residues to the structural changes in perfringolysin O during interaction with liposom al m em branes. NAKAMURA, M., SEKINO, S. N., MITSUI, K. I., and OnNo, I. Y. J. Biochem. ( Tokyo), 1998, 123 (6), 1145–1155.
  • Control of release by m ultivesicular liposom es. WILLIS, R. C., GAI, W., MCALLISTER, D. L., and
  • SAMANIEGO, A. C. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 390–391. Controlled-release of therm al energy and other novel applications of microencapsulation.
  • DAvis, T. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 318–319.
  • COPII-coated vesicle formation reconstituted with purified coat proteins and chemically defined liposom es. MATSUOKA, K., ORCI, L., AMHERDT, M., BEDNAREK, S. Y., HAMAMOTO, S., SCHEKMAN, R., and YEUNG, T. Cell (Cambridge, MA), 1998, 93 (2), 263–275.
  • Cyclolip-cyclosporin liposom al eye drops-in experimental uveitis. SHCHIPANOVA, A. I., and MAICHUK, D. Y. Immunologiya ( Moscow), 1998, (2), 45–47.
  • Degradation of porous poly(anhydride-co-imide) microspheres and implications for con-trolled m acrom olecule delivery. HANES, J., CHIBA, M., and LANGER, R. Biomaterials, 1998, 19 (1-3), 163–172.
  • Delivery of iverm ectin by injectable m icrospheres. MILLER, J. A., OEHLER, D. D., and POUND, J. M. J. Econ. atomoL, 1998, 91 (3), 655–659.
  • Delivery of MUC1 m ucin peptide by poly(D,L-lactic-co-glycolic acid) m icrospheres induces Type 1 T-helper immune responses. NEWMAN, K. D., SOSNOWSKI, D. L., KWON, G. S., and SAMUEL, J. J. Pharm. Sci., 1998, 87 (11), 1421–1427.
  • Developm ent of a new immunosensor for pesticide detection: a disposable system with liposom e-enhancem ent and am perom etric detection. BAUMNER, A. J., and SCHMID, R. D. Biosens. Bioelectron., 1998, 13 (5), 519–529.
  • Developm ent of a new transform ation method using m agnetite cationic liposom es and magnetic selection of transformed cells. NAGATANI, N., SHINKAI, M., HONDA, H., and KOBAYASHI, T. BiotechnoL Tech., 1998, 12 (7), 525–528.
  • Developm ent of a routine analysis method for liposom e encapsulated recom binant inter-leukin -2. KOPPENHAGEN, F. J., STORM, G., UNDERBERG, W. J. M. J. Chromatogr., B: Biomed. AppL, 1998, 716 (1 + 2), 285–291.
  • Developm ent of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA)copolym er m icrospheres in vitro. LEWIS, K. J., IRWIN, W. J., and AKHTAR, S. J. Drug Target., 1998, 5 (4), 291–302.
  • Developm ent of vesicular stom atitis virus (VSV)-liposom es as a novel gene transfer vector. ImAzu, S., NAKAGAWA, S., NAKANISHI, T., HAYAKAWA, T., UEMURA, H., YAMADA, O., and MAYUMI, T. Drug Delivery Syst., 1998, 13 (3), 159–164.
  • Differences in the lipoprotein distribution of free, and liposom e-associated all-trans-retinoic acid in hum an, dog,, and rat plasm a are due to variations in lipoprotein lipid, and protein content. WASAN, K. M., RAMASWAMY, M., NG, S. P., WONG, W., PARROTT, S. C., OJWANG, J. O., WALLACE, T., and Cossum, P. A. Antimicrob. Agents Chemother., 1998, 42 (7), 1646–1653.
  • Direct dissolution of protein in organic solvent for preparation of protein loaded PLGA microspheres. PARK, T. G., LEE, H. Y., and NAM, Y. S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 495–496.
  • Dissolution characteristics of nicardipine hydrochloride microcapsules from hard gelatin capsules and tablets. OZYAZICI, M., SEVGI, F., and ERTAN, G. Acta Pharm. Turc., 1998, 40 (2), 83–89.
  • Distribution and tolerance of biodegradable PLAGA microspheres implanted in the rabbit lumbar subarachnoid space. MENEI, P., CHIROL, J. M., CROUE, A., CRUAUD, O., DENIZOT, B., and BENOIT, J. P. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, /10 /IL
  • Distribution of free and liposom al cefoxitin in plasm a and peritoneal fluid in a porcine intro-abd om in al sepsis model. SHEK, P. N., TIKUISIS, p., ZAMECNIK, J., SOLTES, S., MUSTARD, R. A., and MITTELMAN, M. W. J. Drug Targeting, 1998, 5 (5), 353–364.
  • Effect of combined cyclosporine A and liposome encapsulated dichlorom ethylene dipho-sphonate on the organization of the rat thymus: evidence for a role of m acrophages in guiding the post cyclosporine A thymic reorganization. REZZANI, R., RODELLA, L., and PaANcm, R. Int. J. Immunopharmacol., 1998, 20 (4/5), 183–192.
  • Effect of current on derm al permeation of positively charged liposom es. LAD, M. R., MISRA, A. N., and PATEL, V. B. Indian J. Exp. Biol. 1998, 36 (6), 578–582.
  • Effect of drug-polymer interaction on the release characteristics of m ethacrylic acid copolym er microcapsules containing theophylline. HSIUE, G. H., LIAO, C. M., and UN, S. Y. Artif. Organs, 1998, 22 (8), 651–656.
  • Effect of gas-containing microspheres and echo contrast agents on free radical form ation by ultrasound. KONDO, T., Mism, V., and RIESZ, P. Free Radical Biol. Med., 1998, 25 (4/5), 605–612.
  • Effect of liposom al charge on stavudine transport across rabbit cornea and conjunctiva. KOMPELLA, U. B., KATRAGADDA, A. K., AUKUNURU, J. V., and BETAGERI, G. V. Pharm. PharmacoL Commun., 1998, 4 (7), 339–343.
  • Effect of liposom es-encapsulated dopamine on experimental parkinsonian syndrome in rats after striatum administration. KUCHERVANU, V. G., ZHIGALTSEV, I. V., YURASOV, V. V., KRYZHANOVSKY, G. N., KUDRIN, V. S., KAPLUN, A. P., and SHVETS, V. I. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 5th, /10/1 /105.
  • Effect of saturated/unsaturated PC ratio on the stability of liposom es. HUANG, Y. y and Wu, C. I. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 384–385.
  • Effect of size and charge of liposom es on biodistribution of encapsuled 99m Tc-DTPA in rats. NABAR, S. J., and NADKARNI, G. D. Indian J. PharmacoL, 1998, 30 (3), 199–202.
  • Effect of various cryoprotectants on freeze-drying of liposom es containing Na m ethotrexate. TOLIAT, T., ARAB, N., and RAFIEE, T. M. Proc. Mt. Symp. Controlled Release Bioact. Mater., 1998, 25th, 926–927.
  • Effectiveness of liposom es possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system. HAROKOPAKIS, E., HAJISHENGALLIS, G., and MICHALEK, S. M. Infect. Immtat., 1998, 66 (9), 4299–4304.
  • Effects of lippsom e-encapsulated drugs on m acroph ages: corn paratile activity of the diam dine 4, 6-diamidino-2-phenylindole and the phenanthridinium salts ethidium bromide and propidium iodide. BAKKER, J., SANDERS, A., and VAN ROOIJEN, N. Biochim. Biophys. Acta, 1998, 1373 (1), 93–100.
  • Effects of preparation conditions on the m on odispersity of album in m icrospheres. EL-MAHDY, M., IBRAHIM, E. S., SAFWAT, S., EL- SAYED, A., OHSHIMA, H., MAKINO, K., MURAMATSU, N., and KoNuo, T. J. Microencapsulation, 1998, 15 (5), 661–673.
  • Electrostatic param eters of cationic liposom es comm only used for gene delivery as deter-mined by 4-h eptadecy1-7-hydroxycoum arm. (Erratum to docum ent cited in CA127:298617). ZUIDAM, N. J., and BARENHOLZ, Y. Biochim. Biophys. Acta, 1998, 1372 (1), 151.
  • Em ulsion polym erization of .gam m a.-benzyl L-glutam ate NCA intended for preparation m icrospheres of poly(am ino acid)s. COTO, K., YAMAKAWA, Y., YOSHIDA, Y., and HAYASHI, T. Seitai Zairyo, 1998, 16 (3), 145–151.
  • Enhanced gene transfer into HuH-7 cells and prim ary rat hepatocytes using targeted liposom es and polyethylenim in BANDY0PADHYAY, p., KREN, B. T., MA, X., and STEER, C. J. Bio. Techniques, 1998, 25 (2), 282–284. 286–292.
  • Enhanced im m unogenicity of m icroencapsulated tetanus toxoid with stabilizing agents. AUDRAN, R., MEN, Y., JOHANSEN, P., GANDER, B., and CORRADIN, G. Pharm. Res., 1998, 15 (7), 1111–1116.
  • En han cem ent of cationic liposom e-m ediated transfection by lac toferrin. CHOE, T. B., PARK, I. C., and HONG, S. I. Biotechnol. Tech., 1998, 12 (7), 577–581.
  • Etoposide m icrospheres for targeting to the lung. SCHAEFER, M., and SINGH, J. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 441–442.
  • Evaluation of free and liposom e-encapsulated gen tam ycin for intram uscular sustained release in rabbits. CABANES, A., REIG, F., GARCIA, A. J. M., and ARBOIX, M. Res. Vet. Sci., 1998, 64 (3), 213–217.
  • Evaluation of m icroc apsu le release behavior. Yu, C. H., and THIES, C. Proc. Mt. Symp. Controlled Release Bioact. Miter., 1998, 25th, 294–295.
  • Evaluation of preparation and stability of d oxorubic in encapsulated poly(ethylene glycol)-coated liposom es. HOSODA, J. I., UNEZAKI, S., MARUYAMA, K., and IWATSURU, M. Yakuzaigalcu, 1998, 58 (1), 23–28.
  • Evidence for an acidic m icroclim ate in PLGA m icrosph ere s. SHENDEROVA, A., BURKE, T. G., and SCHWENDEMAN, S. P. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 265–266.
  • Factors affecting degradation rates of poly(lactide-co-glycolide)m icrospheres in vivo3 and in vitro. TRACY, M. A., WARD, K. L., FIROUZABADIAN, L., WANG, Y., DONG, N., QIAN, R., and ZHANG, Y. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 148–149.
  • Flow cytom etry analysis of m icrospheres phagocytosis by alveolar m acroph ages. TORCHE, A. M., ALBINA, E., LE CORRE, p., JESTIN, A., and LE VERGE, R. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 629–630.
  • Fluorescent m icrospheres are superior to radioactive m icrospheres in chronic blood flow e asu rem ents. VAN OOSTERHOUT, M. F. M., PRINZEN, F. W., SAKURADA, S., GLENNY, R. W., and HALER, J. R. S. Am. J. Physiol., 1998, 275 (1, Pt. 2), H110–H115.
  • Formulation optimization of controlled release diclofenac sodium m icrospheres using factorial design. GOHEL, M. C., and AMIN, A. F. J. Controlled Release, 1998, 51 (2-3), 115–122.
  • Gene transfer to vein graft wall by HVJ-liposom e method: time course and localization of gene expression. BAL H. Z., SAWA, Y., ZHANG, W. D., YAMAKAWA, T., MORISHITA, R., KANEDA,Y., and MATSUDA, H. Ann. Thorac. Surg., 1998, 66 (3), 814–819; discussion 819–820.
  • Generation of coated interm ediates of clathrin-m ediated endocytosis on protein-free lipo-som e S. TAKEI, K., HAUCKE, V., SLEPNEV, V., FARSAD, K., SALAZAR, M., CHEN, H., and DE CAMILLI, P. Cell (Cambridge, MA), 1998, 94 (1), 131–141.
  • Giant liposom e having multiple connection holes. ASASHI, K., MIYATA, H., Iro, H., and KINOSHITA, K. Bussei Kenkyu, 1998, 70 (1), 103–104.
  • HEMA/MMMA m icrocapsule implants in hem iparkinsonian rat brain: biocom patibility assessm ent using (3H)PK11195 as a marker for gliosis. CAMPIONI, E. G., NOBREGA, J. N., and SEFTON, M. V. Biomaterials, 1998, 19 (7-9), 829–837.
  • HindIII liposom es suppress delayed-type hypersensitivity responses in vivo and induce epiderm al IL-10 in vitro. NISHIGORI, C., YAROSH, D., O'CONNOR, A., SHREEDHAR, V. K., ULLRICH, S. E., Cox, P., and KRIPKE, M. L. J. Immunol., 1998, 161 (6), 2684–2691.
  • Hum an dystrophin gene expression in m dx muscles after in vivo ballistic transfection, application of synthetic oligopeptide complexes and cationic liposom es. BARANov, V., ZELENTIN, A., TARASINKO, O., KOLESNIKOV, V., MIKHAILOV, V., IVASCHENKO, T., KISELEV, A., ARTEMYEVA, O., EVGRAFOV, O., ZELENINA, I., SHAFEL R., KASCHEEVA, T., DICKSON, G., and I3ARANov, A. NATO ASI Ser., Ser. H, 1998, 105 (Gene Therapy), 219–223.
  • Immobilization of lipase in m icrocapsules prepared by organic and inorganic materials. MATSUMOTO, M., SUMI, N., Oumotu, K., and KONDO, K. Process Biochem. (Oxford), 1998, 33 (5), 535–540.
  • Immobilized liposom e chrom atography for studies of protein-m em brane interactions and refolding of denatured bovine carbonic anhydrase. YOSHIMOTO, M., KUBOI, R., YANG, Q., and MIYAKE, J. J. Chromatogr., B: Biomed. ScL Appl., 1998, 712 (1 + 2), 59–71.
  • Immune responses following pulm onary delivery of PLLA m icrosphere coencapsulated Yersinia pestis antigens. EYLES, J. E., ALPAR, H. O., SPIERS, I. D., and WILLIAMSON, E. D. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 641–642.
  • Im unobiological properties of phospholipid antigens of Rickettsia prow azekii incorporated into rickettsial liposom al preparations. TIMASHEVA, O. A., PETROV, V. F., and TARASEVICH, I. V. Zh. Mikrohiol. Epidemiol. Immunobiol., 1998, Mar-Apr (2), 54–58.
  • Im unoblot analysis of proteins associated with HEMA-MMA m icrocapsules: hum an serum proteins in vitro and rat proteins following implantation. BABENSEE, J. E., CORNELIUS, R. M., BRASH, J. L., and SEFTON, M. V. Biomaterials, 1998, 19 (7-9), 839–849.
  • Im unogen icily and protection against Helicobacter pylori infection with m icroencapsu-lated r-urease form ulations. SOKOLL, K., GUY, B., FRANK, P., Hu, J., CRAIG, S., PSZCZOLKO, H., KLEIN, M., and CHONG, P. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 647–648.
  • Immunological responses with biodegradable polymer m icrospheres. MEN, Y., AUDRAN, R., MERKLE, H. P., GANDER, B., and CORRADIN, G. Drug Targeting Delivery, 1997, 8 (Antigen Delivery Systems), 191–205.
  • Im unom odulation with liposom al MTPPE and IFN-y in gram -negative se ptic e m ia. HAGEN, T. L. M. T. Old Herbom Univ. Semin. Monogr., 1997, 10 (New Antimicrobial Strategies), 47–59.
  • Im unospecific album in m icrospheres containing cisplatin and 5-fluorouracil for intraper-itoneal chem otherapy. TRUTER, E. J., SANTos, A. S., and NEETHUNG, J. H. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 772–773.
  • Im provem ent on preparation of polystyrene m icroshells by m icroencapsulation. Du, K., You, D., ZHANG, L., Zuou, L., and LIN, B. Qiangjiguang Yu Lizishu, 1998, 10 (3), 426–428.
  • Improving stability and release kinetics of m icroencapsulated tetanus toxoid by co-encap-sulation of additives. JOHANSEN, P., MEN, Y., AUDRAN, R., CORRADIN, G., MERKLE, H. P., and GANDER, B. Pharm. Res., 1998, 15 (7), 1103–1110.
  • In -situ form ation of silver nanoparticles on poly(N-isopropylacrylam ide)-coated polystyrene 111 icrospheres. CHEN, C. W., CHEN, M. Q., SERIZAWA, T., and AKASHI, M. Adv. Mater. ( Wefitheim, Ger.), 1998, 10 (14), 1122–1126.
  • In vitro and in vivo assessm ent of liposom es containing recom binant hum an interleukin 2. TIAN, J., and YIN, C. H. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 439–440. In vitro and in vivo release of pulsatile microsphere formulations. MCDANIEL, C. W. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 443'Md.
  • In vitro study of alginate/chitosan m icrospheres for controlled release of the anti-HIV drug T20. YAN, C., ZHANG, H., LAMBERT, D. M., USSERY, M. A., and NIELSEN, C. J. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 510–511.
  • Increase in phospholipase A2 activity tow ards lipopolym er-containing liposom es. VERMEHREN, C., KIEBLER, T., HYLANDER, I., CALLISEN, T. H., and JORGENSEN, K. Biochim. Biophys. Acta, 1998, 1373 (1), 27–36.
  • Increased efficiency of liposom e-m ediated transfection by volume reduction and centrifu-gation. VERMA, R. S., GIANNOLA, D., SHLOMCHIK, W., and EMERSON, S. G. Bio. Techniques, 1998, 25 (1), 46–49.
  • Induction of anti-idiotypic hum oral and cellular immune responses by a m urine m onoclonal antibody recognizing the ovarian carcinom a antigen CA125 encapsulated in biode-gradable 111 icrospheres. MA, J., SAMUEL, J., KWON, G. S., NOUJAIM, A. A., and MADivALARAN, R. Cancer Immunol. Immunother., 1998, 47 (1), 13–20.
  • Induction of protection against tetanus toxin in mice by tetanus toxoid-liposom e conjugate. NAITO, S., HORINO, A., KOMIYA, T., FUKUDA, T., TAKAHASHI, M., Aml, Y., SUZAKI, Y., ORA, T., OKUMA, K., MOROKUMA, M., NAKANO, Y., Mom, M., NISHINOHARA, S., KOMURO, K., and UCHIDA, T. Int. Arch. Allergy Immunol., 1998, 116 (3), 215–219.
  • Induction of protective immune responses against Venezuelan equine encephalitis (YEE) virus aerosol challenge with m icroencapsulated VEE virus vaccine. GREENWAY, T. E., ELDRIDGE, J. H., LUDWIG, G., STAAS, J. K., SMITH, J. F., GILLEY, R. M., and MICHALEK, S. M. Vaccine, 1998, 16 (13), 1314–1323.
  • Influence of additives on the release profile of nifedipine from poly(DL-lactide-co-glycolide) m icrospheres. SANSDRAP, P., and MOFS, A. J. J. Microerzcapsulation, 1998, 15 (5), 545–553.
  • Influence of preparative procedure on m icrosphere characteristics of carboplatin. ZHu, H., JIANG, X., XU, F., and ZHANG, W. Zhongguo Yaoxue Zazhi (Beijing), 1998, 33 (3), 151–153.
  • Influence of processing on the stability and release properties of biodegradable m icrospheres containing thioridazine hydrochloride. O'DONNELL, P. B., and McGrNrry, J. W. Eur. J. Pharm. Biopharm., 1998, 45 (1), 83–94.
  • Influence of some lysosom otropic com pounds on calcium ion desorption process from liposom e m em bran e. KUCZERA, J., WITEK, S., KRAL, T. E., HLADYSZOWSKI, J., LUCZYNSKI, J., and PRZESTALSKI, S. Z Naturforsch, C: Biosci., 1998, 53 (5/6), 389–397.
  • Influence of som e quaternized 1,4-dihydropyridine derivatives on liposom es and erythrocyte m em bran es. TIRZITE, D., KORONOVA, J., and PLOTNIECE, A. Biochem. MoL Biol. Int., 1998, 45 (4), 849–856.
  • Influence of the m icroencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing. WITSCHI, C., and DOELKER, E. J. Controlled Release, 1998, 51 (2-3), 327–341.
  • Inhibition of liposom e-induced corn plem ent activation by incorporated poly(ethylene glycol)-lipids. BRADLEY, A. J., DEvpNE, D. V., ANSELL, S. M., JANZEN, J., and BROOKS, D. E. Arch. Biochem. Biophys., 1998, 357 (2), 185–194.
  • Integrity of m ixed liposom es contacting a polycation depends on the negatively charged lipid content. YAROSLAVOV, A. A., KISELIOVA, E. A. UDALYKH, O. Y., and KABANOV, V. A. Langmuir, 1998, 14 (18), 5160–5163.
  • Interaction of alveolar m acrophages from pulm on ary patients and healthy subjects with liposom es. ATRUZ, O. M., SELISHCHEVA, A. A., SOROKOUMOVA, G. M., ORLOV, S. N., SKRYABIN, G. A., BILICHENKO, T. N., and CHUCHALIN, A. G. Bull. Exp. Biol. Med., 1998, 124 114 1078-1080, 1997.
  • Interaction of lyophilized liposom es with sugar glasses. HINGLE, M. I., LLOYD, A. W., OLLIFF, C. J., MAAS, J., and TAYLOR, P. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 378–379.
  • Interaction of polym yxin B (PXB) with liposom al bilayers. MCALLISTER, S. M., and ALPAR, H. O. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 413–414.
  • Interactions between liposom es and hum an stratum corneum studied by freeze-substitution electron microscopy. VAN DEN BERGH, B. A. I., SALOMONS DE VRIES, I., and BOUWSTRA, J. A. Int. J. Pharm., 1998, 167 (1-2), 57–67.
  • Interfacial indazolization: novel chem ical evidence for rem arkably high exo-surface pH of cationic liposom es used in gene transfection. BANERJEE, R., DAs, P. K., and CHAUDHURI, A. Biochim. Biophys. Acta, 1998, 1373 (2), 299–308.
  • Internal morphology of poly(D,L-lactide-co-glycolide)BCNU-loaded m icrospheres. Influence on drug stability. PAINBENI, T., VENIER, J. M. C., and BENOIT, J. P. EUT . J. Pharm. Biopharm., 1998, 45 (1), 31–39.
  • Intram uscular delivery of LacZ plasm id encapsulated in m icrospheres corn posed of biode-gradable phosphate chain-extended poly(L-lactide). MAO, H. Q., HENDRIKS, B. S., LEN, K. Y., and LEoNo, K. W. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 203–204.
  • Ionic equilibria in m icroheterogeneous system s. Protolytic behavior of indyes inmixed phosphatidylcholine-diphosphatidylglycerol liposom es. GORBENKO, G. p., mcHEDLov, P. N. O., and CHERNAyA, T. A. J. Chem. Soc., Faraday Trans., 1998, 94 (15), 2117–2125.
  • Isolated lung liposom e-m ediated gene transfer produces organ-specific transgenic expres-sion. LEE, R., BOASQUEVISQUE, C. H., BOGLIONE, M. M., HIRATSUKA, M., SCHEULE, R. K., COOPER, J. D., and PATTERSON, G. A. Ann. Thorac. Surg., 1998, 66 (3), 903–907.
  • Kinetic studies of liposom e solubilization by sodium dodecyl sulfate based on a dynamic light scattering technique. LOPEZ, O., COCERA, M., PONS, R., AZEMAR, N., and DE LA MAZA, A. Langmuir, 1998, 14 (16), 4671–4674.
  • Kinetics of molecular transport across a liposom e bilayez. SRIVASTAVA, A., and EISENTHAL, K. B. Chem. Phys. Lett., 1998, 292 (3), 345–351.
  • Limited surface access of porous PLA m icrospheres. EHTEZAZI, T., WASHINGTON, C., and MELIA, C. D. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 707–708.
  • Liposom al cam ptothecin with im proved lactone-m oiety stability and enhanced antitum or activity. CHEN, G., GONG, L., GIOVANELLA, B. C., CHEN, J. R., and CHOW, D. S. L. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 18 119.
  • Liposom al etoposide: in vitro studies on non-m acrophagic and m acrophagic cells. KUMAR, K., SISTLA, A., KOBRINSKY, N. L., and BERRY, E. S. Proc. ITU. Symp. Controlled Release Bioact. Mater., 1998, 25th, 411–412.
  • Liposom al form ulations for oral im m unotherapy. In vitro stability in synthetic intestinal m edia and in vivoeffi cacy in the m ouse. OUADAHI, S., PATERNOSTRE, M., ANDRE, C., GENINT, I., THAo, T. X., PUISIEUX, F., DEVISSAGUET, J. P., and BARRATT, G. J. Drug Targeting, 1998, 5 (5), 365–378.
  • Liposom al re c om bin an t hepatitis B surface antigen. SHENG, F., Du, Z., ZHANG, H., Zuo, Z., LI, J., PENG, J., SHEN, Z., and MA, H. Shengwu Wuli Xuebao, 1997, 13 (4), 589–592.
  • Liposom al tacrolim us and intestinal drug concentration. DUTTA, S., MEZEI, M., LEE, T. D., and MCALISTER, V. C. Transplant. Proc., 1998, 30 (6), 2651–2652.
  • Liposom al tacrolim us: drug m igration within blood corn partm ents. MCALISTER, V. C. Trans-plant. Proc., 1998, 30 (4), 1000–1001.
  • Liposom al vincristine for the treatm ent of hum an acute lym phoblastie leukaem ia in severe combined im m unodeficient (SCID) mice. MILLAR, J. L., MILLAR, B. C., POWLES, R. L., STEELE, J. P., CLUTTERBUCK, R. D., MITCHELL, P. L., Cox, G., FORSSEN, E., and CATOVSKY, D. Br. J. HaematoL, 1998, 102 (3), 718–721.
  • Liposom al VIP attenuates phenylephrine- and ANG II-induced vasoconstriction in vivo. IxEzAlo, H., ONYUKSEL, H., and RUBINSTEIN, I. Am. J. PhysioL, 1998, 275 (2, Pt 2), R588—R595.
  • Liposom e effect on the cytochrome c-catalyzed peroxidation of carbonyl substrates to triplet species. NANTEs, I. L., FALJONI, A. A., VERCESI, A. E., SANTOS, K. E., and BECHARA, E. J. H. Free Radical Biol. Med., 1998, 25 (4/5), 5/16 553.
  • Liposom e encapsulated doxorubicin transfer to the pelvic lymph nodes by endoscopic administration into the bladder wall: a preliminary report. TSURUTA, T., MURAISHI, O., KATSUYAMA, y., MURATA, y., IcHIN0, M., and OGAWA, A. J. UroL, 1997, 157 (5), 1652–1654.
  • Liposom e-anchored vascular endothelial growth factor aptamers. (Erratum to docum ent cited in CA129:180028). WILLIS, M. C., COLLINS, B. D., ZHANG, T., GREEN, L. S., SEBESTA, D. P., BELL, C., KELLOGG, E., GILL, S. C., MAGALLANEZ, A., KNAUER, S., BENDELE, R. A., GILL, P. S., and JANrc, N. Bioconjugate Chem., 1998, 9 (5), 633.
  • Liposom e-based functional drinks. ARNAUD, J. P. Agro. Food Ind. Hi. Tech., 1998, 9 (2), 37–40.
  • Liposom e-based systems for the intravitreal delivery of oligonucleotides. FATTAL, E., BOCHOT, A., MASHHOUR, B., and COUVREUR, P. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 342–343.
  • Liposom e-cell interactions in vitro: effect of liposom e surface charge on the binding and endocytosis of conventional and sterically stabilized liposom es. MILLER, C. R., BONDUR-ANT, B., MCLEAN, S. D., MCGOVERN, K. A., and OBRIEN, D. F. Biochemistry, 1998, 37 (37), 12875–12883.
  • Liposom e-DNA interaction: microcalorimetric study. MREVLISHVILI, G. M., KANaux, B. I., MDZINARASHVILI, T. J., BRELIDZE, T. I., KHVEDELIDZE, M. M., METREVELI, N. O., and RAZMADZE, G. Z. Chem. Phys. Lipids, 1998, 94 (1), 139–143.
  • Liposom e-induced conform ation al changes of an epitopic peptide and its palm itoylated derivative of influenza virus hem agglutinin. LACZKO, I., HOLLOSI, M., VASS, E., TOTH, G. K. Biochem. Biophys. Res. Commun., 1998, 249 (1), 213–217.
  • Liposom e-m ediated DNA vaccination: the effect of vesicle com position. PERRIE, Y., and GREGoRmois, G. IAN Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 623–624.
  • Liposom e-m ediated transfection of fetal lung epithelial cells: DNA degradation and enhanced superoxide toxicity. TANSWELL, A. K., STAUB, O., ILES, R., BELCASTRO, R., CABACUNGAN, J., SEDLACKOVA, L., STEER, B., WEN, Y., Hu, J., and O3 BRODOVICH, H. Am. J. PhysioL, 1998, 275 (3 Pt 1), L452—L460.
  • Liposom es, a potential immunoadjuvant and carrier for a cryptococcal vaccine. LAMBROS, M. P., SCHAFER, F., BLACKSTOCK, R., and MURPHY, J. W. J. Pharm. Sci., 1998, 87 (9), 1144–1148.
  • Liposom es as drug delivery system. A strategic approach for the treatment of HIV infection. DESORMEAUX, A., and BERGERON, M. G. J. Drug Targeting, 1998, 6 (1), 1–15.
  • Liposom es as systemic and mucosal delivery vehicles. VADOLAS, J., WIJBURG, O. L. C., and STRUGNELL, R. A. Drug Targeting Delivery, 1997, 8 (Antigen Delivery Systems), 73–100.
  • Liposom es containing paclitaxel and its hydrophilic prodrugs. CROSASSO, p., BRUSA, p., Dosio, F., Amcco, S., and CATTEL, L. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 392–393.
  • Liposom es for the targeted delivery of superoxide dismutase to arthritic sites. CORVO, M. L., BOERMAN, O. C., OYEN, W. J. G., CRUZ, M. E., CROMMELIN, D. J. A., and STORM, G. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 396–397.
  • Magnetic and m icrobalance techniques for the evaluation of bioadhesive microspheres. A corn parison. HERTZOG, B. A., MOTTL, T. S., CHAN, F., and MATHIOWITZ, E. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 832–833.
  • Manufacture of praziquantel liposome and determination of its encapsulation efficiency. Liu, X., Xmo, H., and SUN, Z. Hunan Nongye Daxue Xuebao, 1998, 24 (3), 251–253.
  • Measuring the encapsulation of cosm etic ingredients into liposom es: a method for large, hydrophilic corn pounds. JMBERT, D., KASTENG, G. B., and WicKETT, R. R. J. Soc. Cosmet. Chem., 1996, 47 (6), 337–349.
  • Membrane fusion plays an important role in gene transfection mediated by cationic lipo-som es. NOGUCHI, A., FURUNO, T., KAWAURA, C., and NAKANISHI, M. FEBS Lett., 1998, 433 (1,2), 169–173.
  • Methotrexate loaded chitosan and chitin microspheres—in vitro characterization and pharm acokinetics in mice bearing Ehrlich ascites carcinoma. SINGH, U. V., and UDUPA, N. J. Microencapsulation, 1998, 15 (5), 581–594.
  • Methylprednisolone in bilayer liposom es prolongs cardiac, and renal allograft survival, inhibits macrophage activation,, and selectively modifies antigen presentation and T helper cell function in rat recipients. BINDER, J., BRAEUTIGAM, R., OERTL, A., KRAMER, W., JONAS, D., HANCOCK, W. W., and KUPIEC-WEGLINSKI, J. W. Transplant Proc., 1998, 30 (4), 1051. Microcalorim etric study on the phase behavior of S-layer coated liposom es. KUPCU, S., LOHNER, K., MADER, C., and SLEYTR, U. B. MoL Membr. Biol., 1998, 15 (2), 69–74.
  • Microen capsulated ferrous sulfate to fortify cow milk: absorption and distribution in mice. Bocci°, J. R., ZUBILLAGA, M. B., CARO, R. A., LYSIONEK, A. E., SALGUEIRO, M. J., CALMANOVICI, G. P., SARABIA, M. I., and WEILL, R. J. Nutr. ScL VitaminoL, 1998, 44 (3), 381–389.
  • Microencapsulated octreotide pam oate in advanced gastrointestinal and pancreatic cancer: a phase I study. HELLE, S. I., GEISLER, J., POULSEN, J. P., HESTDAL, K., MEADOWS, K., COLLINS, W., TVEIT, K. M., VISTE, A., HOLLY, J. M. P., and LONNINTG, P. E. Br. J. Cancer, 1998, 78 (4 14–20.
  • Microencapsulated osmium tetraoxide. A new recoverable and reusable polymer-supported osmium catalyst for dihydroxylation of olefins. NAGAYAMA, S., ENDO, 1\4.5 and KOBAYASHI, S. J. Org. Chem., 1998, 63 (18), 6094–6095.
  • Microencapsulation and pesticide microcapsules. Li, Y., and Ao, C. Nongyao, 1998, 37(7), 4–7. Microencapsulation of antigens for parenteral vaccine delivery systems. KISSEL, T., HILBERT, A. K., KONEBERG, R., and BITTNER, B. Drug Targeting Delivery, 1997, 8 (Antigen Delivery Systems), 159–190.
  • Microencapsulation of cetylpyridinium chloride with a bioadhesive polymer. CONTI, B., MODENA, T., GENTA, I., PERUGINTI, P., DACARRO, C., and PAVANETTO, F. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 822–823.
  • Microencapsulation of orange essential oil. ABURTO, L. C., TAVARES, D. Q., and MARTUCCI, E. T. Cienc. Tecnol. Aliment, 1998, 18 (1), 45–48.
  • Microencapsulation of rhizobacteria by spray-drying: form ulation and survival studies. AMIET, C. C., GADILLE, p., DIGAT, B., and BENOIT, J. P. J. Microencapsulation, 1998, 15 (5), 639–659.
  • Microsphere attachm ent induces glycoprotein redistribution and transmembrane signaling in the Chlam ydom on as flagellum. BLOODGOOD, R. A., and SALOMONSKY, N. L. Protopktsma, 1998, 202 (1-2), 76–83.
  • Migration behavior of dyestuff-containing liposom es in capillary electrophoresis with che-m ilum in escen ce detection. TsuKAGosm, K., OKUMURA, Y., and NAKAJIMA, R. J. Chromatogr., A, 1998, 813 (2), 402–407.
  • Molecular and experimental studies of liposom al morphine association and release. ALAFANDY, M., ROBERT, C., PLAIZIER, J. V., LAUWERS, M., MAES, V., BRASSEUR, R., LEGROS, F. J., and CAMU, F. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 386–387.
  • Molecular characterization and liposom al transfection of a p53-m utated cell line established from a poorly differentiated leiom yosarcom a. MEYE, A., BACHE, M., HINTZE, R., SCHMIDT, H., WuEL, P., HOLZHAUSEN, H. J., RATH, F. W., and TAUBERT, H. Int. J. OncoL, 1998, 13 (2), 241–248.
  • Morphological investigation of crosslinked polystyrene m icrospheres by seeded polym eriza-tion. -YANG, W., MING, W., Hu, J., Lu, X., and Fu, S. Colloid Polym. Sci., 1998, 276 (8), 655–661.
  • Multivesicular liposom e (DepoFoam) technology for the sustained delivery of insulin-like growth factor-I (IGF-D. KATRE, N. V., ASHERMAN, J., SCHAEFER, H., and HORA, M. J. Pharm. Sci., 1998, 87 (11), 1341–1346.
  • Nanotopes. A surfactant resistant carrier system. A comparison with conventional lipo-som es. HERZOG, B., SOMMER, K., BASCHONG, W., and ROEDING, J. SOFW J., 1998, 124 (10), 614, 616, 618, 621–623.
  • New cationic liposom e with enhanced stability and transfection efficiency for gene delivery. KIM, K. M., NAM, B. H., and SOH, D. H. Yakche Hakhoechi, 1998, 28 (2), 93–98.
  • Novel applications of liposom es. LASIC, D. D. Trends BiotechnoL, 1998, 16 (7), 307–321.
  • Onset delay of acoustic second harmonic backscatter from bubbles or microspheres. ZHENG, W., and NEWHOUSE, V. L. Ultrasound Med. Biol., 1998, 24 (4), 513–522.
  • Optim izing a wool dyeing process with an azoic 1:2 metal complex dye using corn m ercially available liposom es. MAZA, A. D. L., CODERCH, L., MANICH, A. M., MARTI, M., PARRA, J. L., and SERRA, S. Text. Res. J., 1998, 68 (9), 635 6/12.
  • Oral delivery of insulin in polymer-coated liposom es. TABBAKHIAN, M., and ROGERS, J. A. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 916–917.
  • Overview of modeling efforts in support of m icroencapsulated polymer mandrel form ation. BooNE, T. D. J. Moscow Phys. Soc., 1998, 8 (1), 79–86.
  • Pegylated-liposom al doxorubicin versus doxorubicin, bleom ycin, and vincristine in the treatm ent of AIDS-related Kaposi's sarcom a: results of a randomized phase III clinical trial. NORTHFELT, D. W., DEZUBE, B. J., THOMMES, J. A., MILLER, B. J., FISCHL, M. A., FRIEDMAN, K. A., KAPLAN, L. D., MOND, C. D., MAMELOK, R. D., and HENRY, D. H. J. Clin. OncoL, 1998, 16 (7), 2445–2451.
  • pH-sensitive liposom es as a carrier for oligonucleotides: a physicochemical study of the interaction between DOPE and a 15-m er oligonucleotide in quasi-anhydrous samples. DE OLIVEIRA, M. C., FATTAL, E., COUVREUR, P., LESIEUR, P., BOURGAUX, C., OLLIVON, M., and DUBERNET, C. Biochim. Biophys. Acta, 1998, 1372 (2), 301–310.
  • pH-sensitive liposom es containing N-isopropylacrylamide copolymers. MEYER, O., PAPAHADJO-POULOS, D., and LEROUX, J. C. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 421–422.
  • pH-sensitive liposom es for receptor-mediated delivery to chicken hepatom a (LMH) cells. SKALKO, N., PESCHKA, R., ALTENSCHMIDT, U., LUNG, A., and SCHUBERT, R. FEBS Lett., 1998, 434 (3), 351–356.
  • Pharm aceutical and therapeutic applications of artificial cells including microencapsula-tion. CHANG, T. NI. Eur. J. Pharm. Biopharm., 1998, 45 (1), 3–8. 51 Refs.
  • Pharm acodynamic evaluation of biodegradable 1713-estradiol microspheres and prostaglan-din F2afor the control of estrus and ovulation in gilts. CUSHMAN, R., BRITT, J. H., DAVIS, P., BOONYAPRAKOB, U., HEDGPETH, V., GIBSON, J., HUDSON, B., and BURNS, P. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 251–252.
  • Pharm acokinetics and relative bioavailability of erythrom ycin microcapsules. ZHANG, G., and JIAN, L. Shenyang Yaoke Dame Xuebao, 1998, 15 (1), 1–2. 28.
  • Pharm acokinetics of pegylated liposom al asODNs. STUART, D. D., and ALLEN, T. M. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 366–367.
  • Pharm acokinetics, tissue distribution, and safety of p-ethoxy oligonucleotides incorporated in liposom es. TARI, A. M., STEPHENS, C., ROSENBLUM, M., and LOPEZ, B. G. J. Liposome Res., 1998, 8 (2), 251–264.
  • Pharm acoscintigraphic evaluation of novel controlled release m icrosphere (Ceform ) for-m ulation S. RICHARDS, J. C., PRIOR, D. V., FRISBEE, S. E., GETZ, J., and WILDING, I. R. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 920–921.
  • Phospholipase cleavage of glycosylphosphatidylinositol reconstituted in liposom al m em - bran es. VILLAR, A. V., Go, F. M., ALONSO, A., JONES, D. R., LEON, Y., and VARELA, N. I. FEBS Lett., 1998, 432 (3), 150–154.
  • Phospholipid components and preparation of liposom es containing protein drugs. YIN, C. H., and HONG, T. L. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 437–438.
  • Physical characterization of polymer-coated liposom es. TABBAKHIAN, M., ANDERSON, K. A., and RoGERs, J. A. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 914–915.
  • Physicochem ical characterization of hum an stratum corneum lipid liposom es. ZELLMER, S., ZIMMERMANN, I., SELLE, C., STERNBERG, B., POHLE, W., and LASCH, J. Chem. Phys. Lipids, 1998, 94 (1), 97–108.
  • Plasm a lipoprotein distribution of liposom al nystatin is influenced by protein content of high-density lipoproteins. CASSIDY, S. M., STROBEL, F. W., and WASAN, K. M. Antimicrob. Agents Chemother., 1998, 42 (8), 1878–1888.
  • Poly(ortho esters) as a m icrocapsulating agents. UN, Y. E., and VASAVADA, R. C. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 719–720.
  • Polylactic acid (biodegradable) m icrospheres for sustained antimicrobial drug release in the equine joint: prelim in ary in vivo re suits. SONDHOF, A. F., MALLAPRAGADA, S., BOOTH, L. C., HEATH, C., ROSENBUSCH, R., APLEY, M., and Hsu, W. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 651–652.
  • Polym eric microcapsules of cyanazine: Preparation and evaluation of efficacy. DAILEY, O. D. JR., and DOWLER, C. C. J. Agric. Food Chem., 1998, 46 (9), 3823–3827.
  • Potential efficacy of gelatin microspheres as a new adjuvant for oral vaccination. YAMASHITA, S., NAKAMURA, M., NADAI, T., SEZAKI, H., KOHNO, T., TABATA, Y., and NADA, Y. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 617–618.
  • Preparation and characterization of 8a-(phosphatidylcholine-dioxy)-alpha-tocopheron es and their form ation during the peroxidation of phosphatidylcholine in liposom es. YAMAUCHI, R., MIZUNO, H., and KATO, K. BioscL Biotechnol. Biochem., 1998, 62 (7), 1293–1300.
  • Preparation and characterization of am picillin loaded methylpyrrolidinone chitosan and chitosan m icrospheres. GIUNCHEDI, P., GENTA, I., Cori, B., MUZZARELLI, R. A., and CONTE, U. Biomaterials 1998, 19 (1-3), 157–161.
  • Preparation and characterization of beta-cyclodextrin and poly(acrylic acid) microspheres. BIBBY, D. C., DAVIES, N. M., and TUCKER, I. G. J. Microencapsulation, 1998, 15 (5), 629–637.
  • Preparation and characterization of Ca-alginate microspheres by a new emulsification method. FUNDUEANU, G., F,SPOSITO, E., MIHAI, D., CARPOV, A., DESBRIERES, J., RINAUDO, M., and NASTRUZZI, C. Int. J. Pharm., 1998, 170 (1), 11–21.
  • Preparation and characterization of pH-sensitive proteinoid microspheres for the oral delivery of m ethotrexate. MADHAN, K. A. B., and PANDURANGA, R. K. Bionzateria4 1998, 19 (7-9), 725–732.
  • Preparation and photoconductivity of C60-containing polystyrene m icrospheres. Hu, J. H., WANG, C. C., YANG, W. L., MING, W. H., and Fu, S. K Gaodeng Xuexiao Huaxue Xuebao, 1998, 19 (8), 1349–1351.
  • Preparation and release property of polylactic acid m icrospheres containing slightly water- soluble drug. TOMIYAMA, N., and NAKANO, M. Byoin Yakugaku, 1998, 24 (3), 205–213.
  • Preparation and tabletting of dipyridam ole alginate-Eudragit m icrospheres. GURSOY, A., KALKAN, F., and OKAR, I. J. Microencapsulation, 1998, 15 (5), 621–628.
  • Preparation of carboplatin-loaded album in m icrosphere and its properties in vitro. ZGu, H., JIANG, K., and Xu, F. Zhongguo Yaoxue Zazhi (Beijing), 1998, 33 (2), 91–94.
  • Preparation of dextran m icrospheres by an all-aqueous system. FRANSSEN, O., and HENNINK, W. E. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 232–233.
  • Preparation of hydrogel m icrospheres by coacervation of aqueous polyphosphazene solutions. ANDRIANOV, A. K., CHEN-, J., and PAYNE, L. G. Biomaterials, 1998, 19 (1-3), 109–115.
  • Preparation of liposom es encapsulating water-soluble com pounds using supercritical carbon dioxide. FREDERIKSEN, L., ANToN, K., VAN HOOGEVEST, p., KELLER, H. R., and LEUENBERGER, H. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 46–47.
  • Preparation of low -m olecular-w eight heparin liposom al spray gel. ZHAI, G. X., Zou, L. J., and ZHANG, T. M. Zhongguo Yiyao Gongye Zazhi, 1998, 29 (6), 261–265.
  • Preparation of m icrospheres of highly crosslinked poly(divinylbenzene) and their surface initiated atom transfer radical polymerization. JANKOVA, K., NGUYEN, K. C., CHEN, X., KOPS, J., JOHANNSEN, I., and BATSBERG, W. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1998, 39 (2), 480–481.
  • Preparation of poly(m ethyl m ethacrylate)m icrospheres modified with amino acid moieties. SHIRAISHI, K., OHNISHI, T., and SUGIYAMA, K. MacromoL Chem. Phys., 1998, 199 (9), 2023–2028.
  • Preparation of silica m icrospheres containing Ag nanoparticle. SHIBATA, S., AOKI, K., YANO, T., and YAMANE, M. J. Sol. Gel. ScL Technol., 1998, 11 (3), 279–287.
  • Progress in study of liposom e-encapsulated drugs against tuberculosis. DENG, K., Liu, R., HuANG, X., WANG, X., and JIN, G. Zhongguo Yaoxue Zazhi (Beijing), 1998, 33 (4), 203–205.
  • Prolonged survival of recipient rats with Fas-ligand-transfected liver allografts by using HVJ-liposom e. Li, X. K., OKUYAMA, T., TAMURA, A., FUJIN°, M., FUNESHIMA, N., KANEDA, y., KITA, Y., ENOSAWA, S., AMEMIYA, H., and Suzum, S. Transplant Proc., 1998, 30 (4), 943.
  • Protein and enzyme immobilization on non-porous m icrospheres of polystyrene. Wu, C. W., LEE, J. G., and LEE, W. C. BiotechnoL AppL Biochem., 1998, 27 (3), 225–230.
  • Protein-based m icrocapsules, and m icrospheres. VELNER, E. M., VINGERHOEDS, M. H., and VAN AMERONGEN, A. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 300–301.
  • Radiation-induced degradation of ionol in aqueous liposom e suspensions in the presence of oxygen. PARAMONOV, D. V., ANTONOVA, E. A., BuGAENito, L. T., TROFIMOV, V. I., and 13yAitov, V. M. High Energy Chem., 1998, 32 (4), 221–225.
  • Rate constants for quenching singlet oxygen and activities for inhibiting lipid peroxidation of carotenoids and Wocopherol in liposom es. FUKUZAWA, K., NoKAmi, y., TOKUMURA, A., TERAO, J., and SUZUKI, A. Lipids, 1998, 33 (8), 751–756.
  • Rats receiving the slimming agent oleoyl-estrone in liposom es (m erlin-2) decrease food intake but maintain therm °genesis. SANCHIS, D., BALADA, F., Pico, C., GRASA, M. M., VIRGIL', J., FARRERONS, C., PALOU, A., FERNANDEZ LOPEZ, J. A., REMESAR, K., and ALEMANY, M. Arch. PhysioL Biochem., 1997, 105 (7), 663–672.
  • Receptor ligand-facilitated cationic liposom e delivery of anti-HIV-1 Rev-binding aptam er and ribozym e DNAs. KONOPKA, K., DUZGUNECS, N., Rossi, J., and LEE, N. S. .1. Drug Target., 1998, 5 (4), 247–259.
  • Remote loading of insulin into liposom es. HWANG, S. H., Qi, X. R., MAITANI, Y., TAKAYAMA, K., and NAGAI, T. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 427–428.
  • Resonant fluorescence in the system atom + dielectric m icrosphere excited by a single photon. Kumov, V. V., and LETOKHOV, V. S. Pis'ma A asp Teor Fiz, 1998, 68 (1-2), 115–120.
  • Rheological properties of gelatin-sodium carboxym ethylcellulose coacerv ate in m icroen- capsulation process. Sovwt, V., and DOKIC, P. ACHModels Chem., 1997, 134 (6),845–852.
  • Safety, tolerance, and pharm acokinetics of a small unilam ellar liposom al form ulation of am photericin B (Am Bisom e) in neutropenic patients. WALSH, T. J., YELDANDI, V., MCEVOY, M., GONZALEZ, C., CHANOCK, S., FREIFELD, A., SEIBEL, N. I., WHITCOMB, P. O., JAROSINSKI, P., BOSWELL, G., BEKERSKY, I., ALAK, A., BUELL, D., BARRET, J., and WILSON, W. Antimicrob. Agents Chemother., 1998, 42 (9), 2391–2398.
  • Separation of hum an bladder cancer cells from bone marrow with a kind of im m unom ag-netic m icrospheres. KANG, J., SAMTEN, B., XIE, S., and WEI, S. Yaoxue Xuebao, 1998, 33 (1), 52–56.
  • Single dose m icroen capsulated flu vaccine form ulations. SOKOLL, K., FRANK, p., Hu, J., CRAIG, S., PSZCZOLKO, H., JAMES, O., BURT, D., KLEIN, M., and CHONG, P. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 649–650.
  • Skin delivery of a hybrid liposome/ISCOM vaccine implicates a role for adjuvants in rapid modulation of inflammatory cells involved in innate immunity before the e n h an ce-m ent of adaptive immune responses. CHIN, J., and Gm, F. S. brirntata. Cell. Biol., 1998, 76 (3), 245–255.
  • Solubilization of ph osph atidylcholine liposom es by the am photeric surfactant dodecyl betaine. DE LA MAZA, A., LOPEZ, O., CODERCH, L., and PARRA, J. L. Chem. Phys. Lipids, 1998, 94 (1), 71–79.
  • Solubilization of phosphatidylcholine unilam ellar liposom es caused by alkyl glucosides. DE LA MAZA, A., Lopaz, 0., I3aucELLs, J., GONZALEZ, P., and PARRA, J. L. J. Surfactants Deterg., 1998,1 (3), 381–386.
  • Stabilization of dichlorom ethane-induced protein denaturation during microencapsulation. RAGHUVANSHI, R. S., GOYAL, S., SINGH, O., and PANDA, A. K. Pharm. Dev. Technol., 1998, 3 (2), 269–276.
  • Stabilization of nerve growth factor during m icroencapsulation and release from m icro-sph eres. LAM, X. M., DUENAS, E. T., and CLELAND, J. L. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 491–492.
  • Stannous ion determ in ation in hum an serum albumin microspheres with attached stannous ion. POTAPOVA, Z. M., EPSTEIN, N. B., KHARITONOV, Y. Y., KFILEattov, V. I., STAROVOYTOVA, L. P., KHARLAMOV, V. T., and SKVORTSOV, V. G. Pharm. PhannacoL Lett., 1998, 8 (3), 103–105.
  • Studies on uptake and sub-cellular trafficking of antisense oligodeoxynucleotides using self-assem bled cationic liposom es as delivery systems. ISLAM, A., THOMPSON, K. S. J., HANDLEY, S. L., and AKHTAR, S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 398–399.
  • Study of m icrospherules in the Perm ian-Triassic boundary of Wanm o section, Guizhou Province, China, by PIXE analysis. CHEINGZHI, Z. Nuovo Cimento Soc. Ital. Fis., C, 1998, 21C (2), 229–235.
  • Study of the imm unobiological properties of Rickettsia prow azekii phospholipid antigens incorporated into rickettsial liposom al preparations. TIMASHEVA, O. A., PETROV, V. F., and TARASEVICH, I. V. Zit MikrobioL, Epidemiol. ImmtmobioL, 1998, (2), 54–58.
  • Study on preparation of diclofenac sodium m icrocapsules and its dissolution. Yu, X., Zuo, H., KANG, L., JIANG, H., and WANG, G. Zhongguo Yiyuan Yaoxue Zazhi, 1998, 18 (2), 65–67.
  • Study on the rifampicin polylac tic acid microspheres for lung targeting. ZHANG, W., JIANG, X., ZHU, C., and Hu, J. Yaoxue Xuebao, 1998, 33 (1), 57–61.
  • Superior efficacy of liposom al am photericin B with prolonged circulation in blood in the treatm ent of severe candidiasis in leukopenic m ice. VAN ETTEN, E. W. M., SNIJDERS, S. V., VAN VIANEN, W., and BAKKER WouDENTBERG, I. A. J. M. Antimicrob. Agents Chemother., 1998, 42 (9), 2431–2433.
  • Sustained cytokine delivery for anticancer vaccination: liposom es as alternative for gene-transfected tumor cells. KOPPENHAGEN, F. J., KUPCU, Z., WALLNER, G., CROMMELIN, D. J., WAGNER, E., STORM, G., and KIRCHEIS, R. Clin. Cancer Res., 1998, 4 (8), 1881–1886.
  • Syntheses of ph ospholipids containing 2-nitrobenzyl ester moieties at the terminals of alkyl chains and properties of photodegradable liposom es from the lipids. YAMAGUCHI, K., TSUDA, y., SHIMAKAGE, T. A., and Kusumt, A. Bull. Chem. Soc. Jpn., 1998, 71 (8), 1923–1929.
  • Synthesis and characterization of polyurethane m icrospheres. RAINIIANATHAN, L. S., SHUKLA, P. G., and SIVARAM, S. Pure AppL Chem., 1998, 70 (6), 1295–1299.
  • Synthesis of am phiphilic phosphate-carbonate copolymers and drug release property of their microspheres. KR, T. Y., and Zuuo, R. X. Gaodeng Xuexiao Huaxue Xuebao, 1998, 19 (8), 1335–1338.
  • Synthesis of divinylbenzene-m aleic anhydride m icrospheres using precipitation polym er-ization. FRANK, R. S., DOWNEY, J. S., and STOVER, H. D. H. J. Polym. Sci., Part A: Polym. Chem., 1998, 36 (13), 2223–2227.
  • Synthesis of microcapsule by Staphylococcus aureus is not responsive to environm ental phosphate concentrations. Fox, K. F., STEWART, G. C., and Fox, A. Infect. Invnun., 1998, 66 (8), 400'1 11007.
  • Targetability of long circulating liposom es modified with am phiphilic PEG conjugated at their distal term in al to TNF-alpha. SAVVA, M., DUDA, E., and HUANG, L. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 854–855.
  • Targeting of soybean-derived steryl glucoside liposom es to liver tum ors in rat and mouse ode iS. SHIMIZU, K., Qt, X. R., MAITANI, y., YOSHII, M., KAWANO, K., TAKAYAMA, K., and NAGAI, T. Biol. Pharm. Bull., 1998, 21 (7), 741–746.
  • Temperature dependence of protein-induced flocculation of phosphatidylcholine liposom es. DIMITROVA, M. N., MATSUMURA, H., NEITCHEV, V. Z., and FURUSAWA, K. Langmuir, 1998, 14 (19), 5438–5445.
  • The chemical microenvironm ent inside biodegradable microspheres during erosion. BRUNNER, A., MADER, K., and GOPFERICH, A. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 154–155.
  • The effect of antioxidants on the kinetics of chain lipid peroxidation in liposom es. VASILEVA, O. V., LYUBITSKII, O. B., KLEBANOV, G. I., and VLADIMIROV, Y. A. Biol. Membr., 1998, 15 (2), 177–183.
  • The effects of a thiol-containing quinazolinedione derivative (MECH) on the lipid oxidation in bilayer liposom es. SCHWINN, J., SPRINZ, H., LEISTNER, S., and BREDE, O. J. RadioanaL Nucl. Chem., 1998, 232 (1-2), 35–37.
  • The entrapm ent of dopamine within liposom es induced by transm em brane am m onium sulfate gradient. ZHIGALTSEV, I. V., KOLOMEITCHUK, S. N., KAPLUN, A. P., YURASOV, V. V., KUCHERYANU, V. G., and SHVETS, V. I. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 417–418.
  • The localizations in liposom al membranes of the tetrahydrofuran ring moieties of the annonaceous acetogenins, annonacin and sylvaticin, as determined by 1H NMR spectroscopy. SHIMADA, H., KOZLOWSKI, J. F., and MCLAUGHLIN, J. L. 47907. PharmacoL Res., 37 (5), 357_364.
  • The physical and chemical stability of suspensions of sustained-release diclofenac m icro- sph eres. LEWIS, L., Bo, R. L., and ADEYEYE, C. M. J. Mcroencapsulation, 1998, 15(5), 555-567. The release of fam otidine from poly(acrylic acid) m icrospheres. DEco,t, Z. Acta Pharm. Turc., 1998, 40 (2), 49–51.
  • The release properties of microcapsules prepared with polym erized latex of Landolphia d u leis. IBEzim, E. C., ESIMONE, C.O, P., and ADIKWU, M. U. Acta Pharm. (Zagreb), 1998, 48 (2), 111–118.
  • The use of 13C solid state NMR to elucidate physico-chem ical association in Eudragit RS100 m icroen capsulated acyl esters of salicylic acid. VACHON, M. G., and NAIRN, J. G. Eur. J. Pharm. Biopharm., 1998, 45 (1), 9–21.
  • Therapy of cancer metastasis by tum oricidal activation of tissue m acrophages using lipo-som e-e n capsu late d im m unom odulators. KILLION, J. J., and FIDLER, I. J. PharmacoL Thu., 1998, 78 (3), 141–154. 135 Refs.
  • Therm osensitive liposom al taxol formulation: heat-mediated targeted drug delivery in 111 urine melanoma. SHARMA, D., CHELVI, T. P., KAUR, J., and RALHAN, R. Melanoma Res., 1998, 8 (3), 240–244.
  • Thiyl radical-induced cis/trans-isom erization of m ethyl linoleate in methanol and of linoleic acid residues in liposom es. SCHWINN, J., SPRINZ, H., DROSSLER, K., LEISTNER, S., and BREDE, O. Int. J. Radiat. Biol., 1998, 74 (3), 359–365.
  • Total antioxidative activity of evening primrose (Oenothera paradoxa) cake extract m ea-sured in vitro by liposom e model and m urine L1210 cells. BALASINSKA, B., and TROS-ZYNSKA, A. J. Agric. Food Chem., 1998, 46 (9), 3558–3563.
  • Transfer of second messengers through gap junction connexin 43 channels reconstituted in liposom es. KAm, Y., KIM, D. Y., Koo, S. K., and JoE, C. O. Biochim. Biophys. Acta, 1998, 1372 (2), 384–388.
  • Treatment of hepatom a bearing rats with liposom e-encapsulatedadriam ycin administered into the hepatic artery. CHEN, J., WANG, Z., Wu, D., Xu, S., and CHEN, H. Disi Junyi Davie Xuebao, 1998, 19 (1), 51–53.
  • Use of biodegradable microspheres in the sustained delivery of antisense oligonucleotides. KHAN, A., BECK, G. F., and AKHTAR, S. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 358–359.
  • Use of dye-containing polymeric microcapsules for determining shear stresses. CLARK, D. C., BAKER, W. E., CoNuo, A. C., and KosowEEI, B. M. Int. Polym. Process, 1998, 13 (3), 239–246.
  • Vasodilation elicited by liposom al VIP is unimpeded by anti-VIP antibody in hamster cheek pouch. IKEZAKI, H., PAUL, S., ALKAN, O. H., PATEL, M., GAO, X. P., and RUB1NSTEIN, I. Am. J. PhysioL, 1998, 275 (1, Pt. 2), R56—R62.
  • Vesicle to micelle structural transitions involved in the interaction of dodecylbetaine with liposom es: transmission electron microscopy and light scattering studies. DE LA MAZA, A., CODERCH, L., LopEz, O., and PARRA, J. L. Micron, 1998, 29 (2/3), 175–182.
  • Virosom es, a new liposom e-like vaccine delivery system. GLUECK, R., and WEGMANN, A. Drug Targeting Delivery, 1997, 8 (Antigen Delivery Systems), 101–122.
  • Visualization of pH in degrading polymer microspheres. FIT, K., PACK, D. W., LAVERDIERE, A., Son, S., and LANGER, R. Proc. Int. Symp. Controlled Release Bioact. Mater., 1998, 25th, 150–151.
  • Wide application of m icrocapsuled asphalt with various characteristics. SEKIGUCHI, I. Funtai Kogaku Kaishi, 1998, 35 (8), 573–583.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.